Lipocine Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lipocine Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Lipocine Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.63M, a 62.7% increase year-over-year.
  • Lipocine Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.29M, a 70.4% increase year-over-year.
  • Lipocine Inc. annual Operating Income (Loss) for 2023 was -$17.9M, a 48% decline from 2022.
  • Lipocine Inc. annual Operating Income (Loss) for 2022 was -$12.1M, a 485% decline from 2021.
  • Lipocine Inc. annual Operating Income (Loss) for 2021 was $3.15M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$17.9M -$5.81M -48% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$12.1M -$15.3M -485% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $3.15M +$21.1M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$18M -$5.1M -39.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$12.9M -$1.57M -13.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$11.3M +$9.89M +46.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$21.2M -$2.03M -10.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$19.2M -$805K -4.38% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 -$18.4M +$2.1M +10.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$20.5M -$9.8M -91.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$10.7M -$14.6M -376% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-11
2012 $3.88M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.